Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Catalyst Pharmaceutical Partners Inc. ( CPRX ) was a big mover last session, as its shares rose nearly 9% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since March 20, as the stock is trading above the volatile price range of $2.21 to $2.39.

In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher can last.

Catalyst Pharmaceutical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other well-performing stocks in the medical sector include WuXi PharmaTech (Cayman) Inc . ( WX ), IntelliPharmaCeutics International ( IPCI ) and Cardiome Pharma Corp. ( CRME ). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

CATALYST PHARMA (CPRX): Free Stock Analysis Report


INTELLIPHARMACT (IPCI): Free Stock Analysis Report

WUXI PHARMATECH (WX): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: CPRX , CRME , IPCI , WX

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by